NGS Goes Global: Nutritional Growth Solutions (ASX: NGS) Announces Transformational Sprout Organic Acquisition

Key Highlights

• Nutritional Growth Solutions to acquire Sprout Organic in an all-scrip $8 million deal
• Sprout brings the world’s first FSANZ-approved organic plant-based infant formula
• Combined group revenue lifts to US$5.33 million on a pro-forma CY2025 basis
• New entity gains access to 1,000-plus retail outlets including Chemist Warehouse
• Shares climb 10% as market reacts to expansion strategy

Shares in Nutritional Growth Solutions Ltd jumped on Monday after the nutrition company unveiled a deal that dramatically expands its scale, product reach and international footprint.

NGS plans to acquire Sprout Organic Pty Ltd in an all-scrip transaction valued at approximately $8 million, marking a major pivot from a niche children’s supplement business into a broader plant-based nutrition platform spanning infancy through adolescence.

NGS shares rose 10% to 2.2 cents in late morning trade, with turnover surging as traders digested the implications of the acquisition.

Under the agreement, NGS will acquire 100% of Sprout Organic through the issuance of roughly 401.2 million shares at a deemed price of 2 cents each.

Source: MarketIndex 

The company also secured firm commitments to raise $2.5 million through a placement at the same price, with proceeds earmarked for integration costs, inventory expansion and marketing.

Importantly, 90% of the shares issued to major Sprout shareholders will remain locked in voluntary escrow for 12 months, reducing the risk of immediate selling pressure following completion.

A broader play across childhood nutrition

The acquisition significantly changes the shape of the business.

Sprout Organic is best known for developing what it describes as the world’s first Food Standards Australia New Zealand approved organic plant-based infant formula, a category that has gained momentum as food allergy awareness and demand for alternative nutrition products continue rising globally.

The company already distributes products through more than 1,000 retail outlets, including Chemist Warehouse, while also maintaining online channels with Coles and Woolworths.

Combined with NGS’s existing Healthy Heights brand, which focuses on nutritional products for children aged three to 12, the merged entity now stretches across a much larger consumer lifecycle.

Infant formula companies often lose customers once children age out of the category. By combining infant, toddler and older child nutrition under one umbrella, the merged group gains a longer runway to retain families within its ecosystem.

On a CY2025 pro-forma basis, the combined group is expected to generate approximately US$5.33 million in revenue, with Sprout contributing US$3.7 million and legacy NGS operations contributing US$1.62 million.

Management also identified around $870,000 in annualised cost savings through corporate rationalisation and operational integration.

Notably, both businesses operate under outsourced manufacturing models, meaning no immediate capital expenditure is required to scale production.

Leadership transition signals strategic reset

The acquisition also triggers a significant management reshuffle.

Sprout founder and chief executive Selasi Berdie will become Group CEO and Executive Director of the combined entity, while Sprout COO Ben Chester steps into the role of Group Chief Operating Officer.

Current interim NGS chief executive Manik Pujara will transition into a Non-Executive Director role.

The leadership changes suggest the company is positioning Sprout’s growth trajectory and distribution experience at the centre of the enlarged business strategy.

The timing comes amid broader growth in plant-based nutrition markets globally.

Research from multiple consumer studies continues to show younger parents increasingly favouring plant-based and allergy-sensitive food alternatives, particularly across premium infant nutrition categories.

Australia has also become one of the world’s most allergy-sensitive consumer markets. Industry estimates suggest up to 10% of Australian infants experience some form of food allergy during early childhood.

That backdrop has turned regulatory approvals into valuable commercial assets.

Food Standards Australia New Zealand approval for infant formula products is widely regarded as one of the more stringent regulatory hurdles in global food markets, creating relatively high barriers to entry for competitors.

The merged business also gains broader geographic leverage.

NGS has built operational strength across Amazon and Shopify channels in the United States, while Sprout has established pharmacy distribution and export pathways into markets including China and Malaysia.

The transaction still requires shareholder approval, expected at an upcoming AGM in July 2026.

Attention will now shift toward how quickly the combined group can integrate operations, expand distribution and narrow its pro-forma EBITDA losses through planned synergies.

For a company with a market value of just over $7 million prior to the announcement, Monday’s deal represents a substantial strategic swing.